(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 6.59% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Tilray Brands's revenue in 2025 is $826,656,000.On average, 6 Wall Street analysts forecast TLRY's revenue for 2026 to be $901,529,472,373, with the lowest TLRY revenue forecast at $876,959,900,324, and the highest TLRY revenue forecast at $943,086,682,662. On average, 4 Wall Street analysts forecast TLRY's revenue for 2027 to be $945,124,836,912, with the lowest TLRY revenue forecast at $891,050,843,288, and the highest TLRY revenue forecast at $1,003,476,438,222.
In 2028, TLRY is forecast to generate $1,015,655,038,927 in revenue, with the lowest revenue forecast at $968,450,379,997 and the highest revenue forecast at $1,062,859,697,856.